126 related articles for article (PubMed ID: 28120044)
1. Long term follow-up of cerebrovascular abnormalities in late onset Pompe disease (LOPD).
Garibaldi M; Sacconi S; Antonini G; Desnuelle C
J Neurol; 2017 Mar; 264(3):589-590. PubMed ID: 28120044
[No Abstract] [Full Text] [Related]
2. Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD).
Montagnese F; Granata F; Musumeci O; Rodolico C; Mondello S; Barca E; Cucinotta M; Ciranni A; Longo M; Toscano A
J Inherit Metab Dis; 2016 May; 39(3):391-398. PubMed ID: 26830551
[TBL] [Abstract][Full Text] [Related]
3. Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease.
Hensel O; Schneider I; Wieprecht M; Kraya T; Zierz S
Orphanet J Rare Dis; 2018 Apr; 13(1):57. PubMed ID: 29653542
[TBL] [Abstract][Full Text] [Related]
4. Toward deconstructing the phenotype of late-onset Pompe disease.
Schüller A; Wenninger S; Strigl-Pill N; Schoser B
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):80-8. PubMed ID: 22253010
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system involvement in late-onset Pompe disease: clues from neuroimaging and neuropsychological analysis.
Musumeci O; Marino S; Granata F; Morabito R; Bonanno L; Brizzi T; Lo Buono V; Corallo F; Longo M; Toscano A
Eur J Neurol; 2019 Mar; 26(3):442-e35. PubMed ID: 30312517
[TBL] [Abstract][Full Text] [Related]
6. Bright tongue sign in patients with late-onset Pompe disease.
Karam C; Dimitrova D; Yutan E; Chahin N
J Neurol; 2019 Oct; 266(10):2518-2523. PubMed ID: 31256280
[TBL] [Abstract][Full Text] [Related]
7. The emerging phenotype of late-onset Pompe disease: A systematic literature review.
Chan J; Desai AK; Kazi ZB; Corey K; Austin S; Hobson-Webb LD; Case LE; Jones HN; Kishnani PS
Mol Genet Metab; 2017 Mar; 120(3):163-172. PubMed ID: 28185884
[TBL] [Abstract][Full Text] [Related]
8. Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.
Pichiecchio A; Sacco S; De Filippi P; Caverzasi E; Ravaglia S; Bastianello S; Danesino C
J Neurol; 2017 Oct; 264(10):2110-2118. PubMed ID: 28856460
[TBL] [Abstract][Full Text] [Related]
9. Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature.
Hobson-Webb LD; Proia AD; Thurberg BL; Banugaria S; Prater SN; Kishnani PS
Mol Genet Metab; 2012 Aug; 106(4):462-9. PubMed ID: 22664150
[TBL] [Abstract][Full Text] [Related]
10. Teaching Video NeuroImages: The Beevor sign in late-onset Pompe disease.
Garibaldi M; Diaz-Manera J; Gallardo E; Antonini G
Neurology; 2016 Jun; 86(24):e250-1. PubMed ID: 27298456
[No Abstract] [Full Text] [Related]
11. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
[TBL] [Abstract][Full Text] [Related]
12. Pompe disease in Austria: clinical, genetic and epidemiological aspects.
Löscher WN; Huemer M; Stulnig TM; Simschitz P; Iglseder S; Eggers C; Moser H; Möslinger D; Freilinger M; Lagler F; Grinzinger S; Reichhardt M; Bittner RE; Schmidt WM; Lex U; Brunner-Krainz M; Quasthoff S; Wanschitz JV
J Neurol; 2018 Jan; 265(1):159-164. PubMed ID: 29181627
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Yield of Chilaiditi's Sign in Advanced-Phase Late-Onset Pompe Disease.
Takahashi J; Mori-Yoshimura M; Ariga H; Sato N; Nishino I; Takahashi Y
J Neuromuscul Dis; 2022; 9(5):619-627. PubMed ID: 35964201
[TBL] [Abstract][Full Text] [Related]
14. Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study.
Figueroa-Bonaparte S; Llauger J; Segovia S; Belmonte I; Pedrosa I; Montiel E; Montesinos P; Sánchez-González J; Alonso-Jiménez A; Gallardo E; Illa I; ; Díaz-Manera J
Sci Rep; 2018 Jul; 8(1):10898. PubMed ID: 30022036
[TBL] [Abstract][Full Text] [Related]
15. The impact of antibodies in late-onset Pompe disease: a case series and literature review.
Patel TT; Banugaria SG; Case LE; Wenninger S; Schoser B; Kishnani PS
Mol Genet Metab; 2012 Jul; 106(3):301-9. PubMed ID: 22613277
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease.
Sacconi S; Bocquet JD; Chanalet S; Tanant V; Salviati L; Desnuelle C
J Neurol; 2010 Oct; 257(10):1730-3. PubMed ID: 20559845
[TBL] [Abstract][Full Text] [Related]
17. Patients' perspectives on newborn screening for later-onset lysosomal storage diseases.
Lisi EC; Gillespie S; Laney D; Ali N
Mol Genet Metab; 2016 Sep; 119(1-2):109-14. PubMed ID: 27591925
[TBL] [Abstract][Full Text] [Related]
18. Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy.
Lollert A; Stihl C; Hötker AM; Mengel E; König J; Laudemann K; Gökce S; Düber C; Staatz G
PLoS One; 2018; 13(1):e0190784. PubMed ID: 29315315
[TBL] [Abstract][Full Text] [Related]
19. Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered.
El-Gharbawy AH; Bhat G; Murillo JE; Thurberg BL; Kampmann C; Mengel KE; Kishnani PS
Mol Genet Metab; 2011 Aug; 103(4):362-6. PubMed ID: 21605996
[TBL] [Abstract][Full Text] [Related]
20. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management.
Kishnani PS; Beckemeyer AA; Mendelsohn NJ
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):1-7. PubMed ID: 22253049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
